ArticlePathology oncology research : POR2018

Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.

Glenda Nicioli da Silva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.